In this review, we summarize evidence regarding the use of routine and investigational
pharmacologic interventions for pregnant and lactating patients with coronavirus disease …

A course of antenatal corticosteroids given within the seven days prior to preterm birth
reduces perinatal and neonatal death and respiratory distress syndrome.[Grade A] For …

GC Di Renzo a, L. Cabero Roura b, F. Facchinetti c, H. Helmer d, C. Hubinont e, B.
Jacobsson f, JS Jørgensen g, RF Lamont h, i, A. Mikhailov j, N. Papantoniou k, V. Radzinsky …

Sex differences in the anatomy and physiology of the respiratory system have been widely
reported. These intrinsic sex differences have also been shown to modulate the …

Objective To evaluate the effectiveness of antenatal corticosteroids given at≥ 34 weeks'
gestation. Design Systematic review with meta-analysis. Data sources Electronic databases …

Hypertensive disorders affect as many as 10% of all pregnancies worldwide. 1 This
heterogeneous group of disorders includes chronic hypertension, gestational hypertension …

Recent evidence supports the use of an early, short course of glucocorticoids in patients with
COVID-19 who require mechanical ventilation or oxygen support. As the number of …

Transient tachypnea of newborn (TTN) results from failure of the newborn to effectively clear
the fetal lung fluid soon after birth. TTN represents the most common etiology of respiratory …

Antenatal corticosteroids are standard of care for pregnancies at risk of preterm delivery
between 24-34 weeks' gestational age. Recent trials demonstrate modest benefits from …

Novel coronavirus disease 2019 (COVID-19) is a respiratory tract infection that was first
identified in China. Since its emergence in December 2019, the virus has rapidly spread …